NewHold Investment Corp IV is a special purpose acquisition company (SPAC) designed to identify and merge with innovative, high-growth businesses in technology and healthcare sectors. As a publicly traded entity, NHIV aims to leverage its capital and industry expertise to foster the development of next-generation companies. With a strong focus on value creation and strategic partnerships, NewHold Investment Corp IV is positioned to capitalize on emerging market trends and deliver significant returns for its investors. The company's leadership is composed of experienced professionals with a proven track record in operational management and investment, further enhancing its capability to drive successful mergers.
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | — |
| Operating Margin | 0.00% |
| Return on Equity | 0.00% |
| Return on Assets | 0.00% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $-0.01 |
| Price-to-Book | — |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $20.77M |
| Float | $19.29M |
| % Insiders | 0.00% |
| % Institutions | 0.00% |